UBS Group
RNLX

UBS Group’s Renalytix plc American Depositary Shares RNLX Stock Holding History

UBS Group’s Portfolio RNLX Stock Details RNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-279,743
Closed -$58.5K – 10751
2024
Q3 		$58.5K Buy
279,743
+279,668
+372,891% +$89.4K ﹤0.01% 6716
2024
Q2 		$17 Buy
+75
New +$45 ﹤0.01% 9324
2023
Q4 		– Sell
-4,061
Closed -$6.5K – 10138
2023
Q3 		$6.5K Sell
4,061
-2,349
-37% -$6.49K ﹤0.01% 7297
2023
Q2 		$18.7K Buy
6,410
+6,177
+2,651% +$14K ﹤0.01% 6908
2023
Q1 		$564 Sell
233
-7,727
-97% -$21.4K ﹤0.01% 8973
2022
Q4 		$14.9K Buy
7,960
+6,460
+431% +$10.1K ﹤0.01% 8036
2022
Q3 		$2K Buy
1,500
+1,000
+200% +$2.18K ﹤0.01% 9814
2022
Q2 		$1K Sell
500
-100
-17% -$476 ﹤0.01% 10035
2022
Q1 		$4K Sell
600
-2,543
-81% -$26.9K ﹤0.01% 9345
2021
Q4 		$50K Buy
3,143
+1,643
+110% +$32.9K ﹤0.01% 6898
2021
Q3 		$30K Sell
1,500
-4,100
-73% -$106K ﹤0.01% 6765
2021
Q2 		$173K Buy
5,600
+3,600
+180% +$108K ﹤0.01% 5465
2021
Q1 		$51K Buy
2,000
+1,341
+203% +$33.6K ﹤0.01% 6531
2020
Q4 		$11K Buy
+659
New +$8.13K ﹤0.01% 7439

Other funds holding RNLX

XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
IIC
Ironwood Investment Counsel Scottsdale, Arizona $762M AUM 23.02% 1-Year Est. Return

UBS Group's RNLX Position: Q4 2024 in Review

UBS Group sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2024, closing a stake of 279,743 shares — an estimated $58.5K sold.

UBS Group first reported a position in RNLX in Q4 2020 and held it in 14 quarters. The position peaked at $173K in Q2 2021. 3 funds tracked by Wall St. Rank hold RNLX as of Q4 2024.

  • UBS Group reported no remaining Renalytix plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • UBS Group sold 279,743 Renalytix plc American Depositary Shares shares in Q4 2024, an estimated $58.5K.
  • UBS Group first reported a position in Renalytix plc American Depositary Shares in Q4 2020 and held it in 14 quarters.
  • UBS Group's Renalytix plc American Depositary Shares position peaked at $173K in Q2 2021.
  • 3 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2024.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.